"Medicata pharma", MB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
23,025 |
- |
3,288 |
3,124 |
- |
0.22 |
2.16 |
21.04 |
13.57 |
6,197 |
13,371 |
1,189 |
18,379 |
2023 |
---|
27,675 |
- |
-830 |
-830 |
- |
0.18 |
0.64 |
3.37 |
-3.00 |
5,793 |
3,697 |
819 |
8,671 |
2024 |
---|
21,287 |
- |
-11 |
-11 |
- |
0.60 |
0.09 |
3.21 |
-0.05 |
13,352 |
1,135 |
576 |
13,911 |
Register and
explore Okredo data2024 |
---|
21,287 |
- |
-11 |
-11 |
- |
0.60 |
0.09 |
3.21 |
-0.05 |
13,352 |
1,135 |
576 |
13,911 |
Register and
explore Okredo data2024
Turnover (€)
21,287 €-23 % *
Sales per employee (€)
-Profit before tax (€)
-11 €99 % *
Net Profit (€)
-11 €99 % *
Profit per employee (€)
-Working capital requirement
0.60 233.33 % *
Debt-to-equity ratio
0.09 -85.94 % *
Total profitability (%)
3.21 %-4.75 % *
Net profitability (%)
-0.05 %98.33 % *
Equity (€)
13,352 €130 % *
Amounts Payable And Liabilities (€)
1,135 €-69 % *
Non-current Assets (€)
576 €-30 % *
CurrentAssets (€)
13,911 €60 % *